Instillagel (Chlorhexidine Gluconate, Lidocaine Hydrochloride)

Chlorhexidine gluconate acts as a broad‑spectrum antiseptic by binding to bacterial cell membranes, disrupting their structure and causing leakage of intracellular contents, which leads to cell death. This rapid antimicrobial action reduces the bacterial load on the urethral mucosa, lowering the risk of infection during invasive procedures.

The dose of Instillagel is determined by the prescribing clinician based on the specific procedure and patient needs. Typically, a measured amount of gel is instilled into the urethra immediately before catheter insertion or the intended intervention. Exact volume and frequency should follow the healthcare professional’s instructions.

Safety data for Instillagel in pregnancy and lactation are limited. It should only be used when the expected benefit outweighs any potential risk to the fetus or infant. Healthcare providers should evaluate each case individually and discuss possible concerns with the patient before administration.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Instillagel. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. After verification, the team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Instillagel uniquely combines a potent antiseptic (chlorhexidine) with a local anaesthetic (lidocaine) in a single gel, offering both infection control and pain relief. Many alternative products provide only antiseptic action or require a separate anaesthetic, which can increase procedural steps and cost. Instillagel’s dual action simplifies preparation and may improve patient comfort.

Instillagel should be stored at room temperature, preferably below 25 °C, in its original sealed container. Protect the gel from direct sunlight, excessive heat, and moisture. Do not freeze the product, and keep it out of reach of children. Check the label for the expiry date before use.

Instillagel is applied directly into the urethra using a sterile applicator or syringe as directed by the clinician. The gel is typically instilled shortly before catheter insertion or the planned procedure, allowing the lidocaine to provide local anaesthesia while the chlorhexidine exerts its antiseptic effect. Administration should be performed under aseptic conditions.

The most serious risks include severe allergic reactions such as anaphylaxis, significant urethral ulceration or necrosis, and systemic lidocaine toxicity, which can manifest as neurological or cardiac symptoms. Immediate medical attention is required if any signs of severe hypersensitivity, persistent pain, or systemic toxicity develop after application.

Instillagel should be avoided in patients with known hypersensitivity to chlorhexidine, lidocaine, or any component of the formulation. It is also contraindicated in individuals with severe urethral injury, active ulceration, or infection at the application site. Clinicians should assess each patient’s medical history before prescribing.